These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17370595)

  • 1. [Molecular target therapy for colonic neoplasms].
    Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
    [No Abstract]   [Full Text] [Related]  

  • 2. [New developments in immunotherapy for digestive system diseases].
    Imai K
    Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1901-7. PubMed ID: 16223155
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological agents versus chemotherapy in the treatment of colorectal cancer.
    Eng C; Shalan N
    Expert Opin Pharmacother; 2006 Jul; 7(10):1251-71. PubMed ID: 16805714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology evaluation: bevacizumab, Genentech/Roche.
    Salgaller ML
    Curr Opin Mol Ther; 2003 Dec; 5(6):657-67. PubMed ID: 14755893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accrual delayed in adjuvant bevacizumab trial.
    Tuma RS
    J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed news for Avastin.
    Mack GS
    Nat Biotechnol; 2009 Jun; 27(6):494. PubMed ID: 19513035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?].
    André T; Larsen AK; de Gramont A
    Bull Cancer; 2012 Jun; 99(6):607-8. PubMed ID: 22900267
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab.
    El Maalouf G; Mitry E; Lacout A; Lièvre A; Rougier P
    J Neurol; 2008 Feb; 255(2):295-6. PubMed ID: 18283405
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies in the treatment of advanced colorectal cancer.
    Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis inhibitors in cancer therapy. Bevacizumab against colon carcinoma].
    Fieth C; Kebig A; Mohr K
    Pharm Unserer Zeit; 2007; 36(6):442-5. PubMed ID: 17957688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw and bevacizumab therapy.
    Van Poznak C
    Breast Cancer Res Treat; 2010 Jul; 122(1):189-91. PubMed ID: 20464477
    [No Abstract]   [Full Text] [Related]  

  • 12. [A perspective: role of targeted therapy in colon cancer].
    Chung HH; Jang BI
    Korean J Gastroenterol; 2013 Mar; 61(3):128-35. PubMed ID: 23575231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular-based treatment concepts in advanced pancreatic cancer].
    Boeck S; Moosmann N; Stemmler HJ; Heinemann V
    Dtsch Med Wochenschr; 2007 Apr; 132(15):818-22. PubMed ID: 17427093
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular toxicity of new agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular endothelial growth factor inhibitors in colon cancer.
    Díaz-Rubio E
    Adv Exp Med Biol; 2006; 587():251-75. PubMed ID: 17163170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caution in adding bevacizumab in the adjuvant treatment of breast cancer.
    Ziogas D; Roukos D
    Ann Surg Oncol; 2010 Feb; 17(2):653-4; author reply 655-6. PubMed ID: 19888632
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody treatment in colorectal cancer--what the surgeon needs to know].
    Thalheimer A; Illert B; Reimer P; Bueter M; Thiede A; Gasser M; Fein M; Waaga-Gasser AM; Meyer D
    Zentralbl Chir; 2008 Apr; 133(2):101-6. PubMed ID: 18415895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological therapy update in colorectal cancer.
    Sorscher SM
    Expert Opin Biol Ther; 2007 Apr; 7(4):509-19. PubMed ID: 17373902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted agents for adjuvant therapy of colon cancer.
    Saif MW
    Clin Colorectal Cancer; 2006 May; 6(1):46-51. PubMed ID: 16796791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target.
    Meropol NJ
    J Clin Oncol; 2005 Mar; 23(9):1791-3. PubMed ID: 15677698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.